Naloxone and the narcotic abuser

A controlled study of partial blockade

Albert A. Kurland, Thomas E. Hanlon, Oliver Lee McCabe

Research output: Contribution to journalArticle

Abstract

Within the framework of an ongoing urine monitoring program, 119 paroled narcotic addicts were randomly assigned to either urine monitoring alone (concurrent control) or to double-blind treatment with either placebo or Naloxone at a partial blockade dosage level (200 to 800 mg daily). Outcome assessments at 6 and 9 months tended to favor "pill-takers" over concurrent controls. Although there were no significant differences between placebo and Naloxone in terms of retention rates and the maintenance of complete abstinence, there was considerably less narcotic drug use by Naloxone-treated subjects. Side effects were judged to be minimal and of little consequence. The importance of motivation on the part of the addict in the narcotic antagonist approach is stressed.

Original languageEnglish (US)
Pages (from-to)663-672
Number of pages10
JournalSubstance Use and Misuse
Volume9
Issue number5
DOIs
StatePublished - 1974
Externally publishedYes

Fingerprint

Narcotics
Naloxone
drug
addiction
Placebos
Urine
monitoring
Narcotic Antagonists
drug use
Maintenance
Outcome Assessment (Health Care)
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Public Health, Environmental and Occupational Health
  • Health(social science)
  • Medicine (miscellaneous)

Cite this

Naloxone and the narcotic abuser : A controlled study of partial blockade. / Kurland, Albert A.; Hanlon, Thomas E.; McCabe, Oliver Lee.

In: Substance Use and Misuse, Vol. 9, No. 5, 1974, p. 663-672.

Research output: Contribution to journalArticle

Kurland, Albert A. ; Hanlon, Thomas E. ; McCabe, Oliver Lee. / Naloxone and the narcotic abuser : A controlled study of partial blockade. In: Substance Use and Misuse. 1974 ; Vol. 9, No. 5. pp. 663-672.
@article{13971c6309c9465f8f8611439f7fa3fe,
title = "Naloxone and the narcotic abuser: A controlled study of partial blockade",
abstract = "Within the framework of an ongoing urine monitoring program, 119 paroled narcotic addicts were randomly assigned to either urine monitoring alone (concurrent control) or to double-blind treatment with either placebo or Naloxone at a partial blockade dosage level (200 to 800 mg daily). Outcome assessments at 6 and 9 months tended to favor {"}pill-takers{"} over concurrent controls. Although there were no significant differences between placebo and Naloxone in terms of retention rates and the maintenance of complete abstinence, there was considerably less narcotic drug use by Naloxone-treated subjects. Side effects were judged to be minimal and of little consequence. The importance of motivation on the part of the addict in the narcotic antagonist approach is stressed.",
author = "Kurland, {Albert A.} and Hanlon, {Thomas E.} and McCabe, {Oliver Lee}",
year = "1974",
doi = "10.3109/10826087409057380",
language = "English (US)",
volume = "9",
pages = "663--672",
journal = "Substance Use and Misuse",
issn = "1082-6084",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Naloxone and the narcotic abuser

T2 - A controlled study of partial blockade

AU - Kurland, Albert A.

AU - Hanlon, Thomas E.

AU - McCabe, Oliver Lee

PY - 1974

Y1 - 1974

N2 - Within the framework of an ongoing urine monitoring program, 119 paroled narcotic addicts were randomly assigned to either urine monitoring alone (concurrent control) or to double-blind treatment with either placebo or Naloxone at a partial blockade dosage level (200 to 800 mg daily). Outcome assessments at 6 and 9 months tended to favor "pill-takers" over concurrent controls. Although there were no significant differences between placebo and Naloxone in terms of retention rates and the maintenance of complete abstinence, there was considerably less narcotic drug use by Naloxone-treated subjects. Side effects were judged to be minimal and of little consequence. The importance of motivation on the part of the addict in the narcotic antagonist approach is stressed.

AB - Within the framework of an ongoing urine monitoring program, 119 paroled narcotic addicts were randomly assigned to either urine monitoring alone (concurrent control) or to double-blind treatment with either placebo or Naloxone at a partial blockade dosage level (200 to 800 mg daily). Outcome assessments at 6 and 9 months tended to favor "pill-takers" over concurrent controls. Although there were no significant differences between placebo and Naloxone in terms of retention rates and the maintenance of complete abstinence, there was considerably less narcotic drug use by Naloxone-treated subjects. Side effects were judged to be minimal and of little consequence. The importance of motivation on the part of the addict in the narcotic antagonist approach is stressed.

UR - http://www.scopus.com/inward/record.url?scp=84907120705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907120705&partnerID=8YFLogxK

U2 - 10.3109/10826087409057380

DO - 10.3109/10826087409057380

M3 - Article

VL - 9

SP - 663

EP - 672

JO - Substance Use and Misuse

JF - Substance Use and Misuse

SN - 1082-6084

IS - 5

ER -